Protalix BioTherapeutics logo
Protalix BioTherapeutics PLX
$ 1.64 -2.96%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Protalix BioTherapeutics Cost of Revenue 2011-2024 | PLX

Annual Cost of Revenue Protalix BioTherapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
23 M 19.6 M 16.3 M 10.9 M 10.9 M 9.3 M 15.2 M 8.4 M 730 K 630 K - 8.14 M 1.52 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
23 M 630 K 10.4 M

Quarterly Cost of Revenue Protalix BioTherapeutics

2024-Q3 2024-Q2 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
8.38 M 9.46 M 4.89 M 6.15 M 3.08 M - 7.07 M 4.09 M 6.03 M - 3.7 M 4.73 M 4.76 M - 2.87 M 1.83 M 3.43 M - 3.2 M 2.7 M 2.04 M - 1.92 M 2.18 M 2.92 M - 6.07 M 5.52 M 2.09 M - 4.25 M 1.68 M 523 K - 223 K 225 K 282 K - 1.8 M 1.6 M 4.07 M - 1.59 M 1.32 M 971 K - 2.37 M 3.28 M 1.32 M - 220 K 132 K 778 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
9.46 M 132 K 3.07 M